A major research interest is the application of human recombinant antibodies and antibody fragments in medical and industrial applications, as well as studies of mechanisms underlying somatic mutations in B cells and IgE switch in allergy. The use of synthetic antibodies in proteome analysis, including protein array technology is also pursued as well as gene array analysis of the transcriptome. B cell malignancies is one focus in antibody and gene therapy projects as well as viral infection in molecular breeding projects.
The major research area is the development of soft- and hardware for protein separation and identification for biomedical applications, in particular in cancer. The research is focussed on developing basic methodologies such as protein-protein interaction and membrane protein analysis to be used for population studies of disease.
We are connected by an aerial walkway to the main hospital and by underground passage to the department of oncology. The development of high-throughput analysis methods and infrastructure is focussed on the rapidly growing area of clinical proteomics and is especially relevant in Sweden where there are large, well-documented biobanks.
Page Manager: Mats Ohlin
Last updated: 2011-05-03